The importance of dose, frequency and duration of vitamin d supplementation for plasma 25-hydroxyvitamin d

Nutrients

Volumn 5, Issue 10, 2013, Pages 4067-4078

  Chao, Yi Sheng ^a   Brunel, Ludovic ^b   Faris, Peter ^c   Veugelers, Paul J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Santessence   (Canada)

^c Alberta Bone and Joint Health Institute   (Canada)

Author keywords

25 hydroxyvitamin d (25(OH)D); Dose response; Duration; Frequency; Vitamin d

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; POPULATION RESEARCH; SELF CONCEPT; SMOKING; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; VOLUNTEER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; QUESTIONNAIRES; REGRESSION ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84885904154     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5104067     Document Type: Article

References (35)

1. Ceglia, L.; Simpson, R.U. Vitamin D and Skeletal Muscle Function. In Vitamin D; Feldman, D., Pike, J.W., Adams, J.S., Eds.; Elsevier Science: Amsterdam, The Netherlands, 2011.
2. Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D; The National Academies Press: Washington, DC, USA, 2011.
3. Chung, M.; Balk, E.; Brendel, M.; Ip, S.; Lau, J.; Lee, J.; Lichtenstein, A.; Patel, K.; Raman, G.; Tatsioni, A. et al. Vitamin D and Calcium: Systematic Review of Health Outcomes; Evidence Report/Technology Assessment No. 183. (Prepared by Tufts Evidence-Based Practice Center under Contract No. 290-2007-10055-i); Agency for Healthcare Research and Quality: Rockville, MD, USA, 2009.
4. Holick, M.F. Vitamin D: Physiology, Molecular Biology, and Clinical Applications; Humana Press: New York, NY, USA, 2010.
5. Heaney, R.P. Serum 25-hydroxyvitamin d is a reliable indicator of vitamin D status. Am. J. Clin. Nutr. 2011, 94, 619-620.
6. Lappe, J.M.; Davies, K.M.; Travers-Gustafson, D.; Heaney, R.P. Vitamin D status in a rural postmenopausal female population. J. Am. Coll. Nutr. 2006, 25, 395-402.
7. Viljakainen, H.T.; Palssa, A.; Karkkainen, M.; Jakobsen, J.; Lamberg-Allardt, C. How much vitamin D3 do the elderly need? J. Am. Coll. Nutr. 2006, 25, 429-435.
8. Heaney, R.P. Vitamin d in health and disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1535-1541.
9. Heaney, R.P. The vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol. 2005, 97, 13-19.
10. Vieth, R. Vitamin D supplementation, 25-hydroxyvitamin d concentrations, and safety. Am. J. Clin. Nutr. 1999, 69, 842-856.
11. Vieth, R. The Pharmacology of Vitamin D, Including Fortification Strategies. In Vitamin D; Feldman, D., Glorieux, F., Pike, J., Eds.; Elsevier: New York, NY, USA, 2005; pp. 995-1015.
12. Holick, M.F. Vitamin D. In Modern Nutrition in Health and Disease; Shils, M.E., Shike, M.E.S.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006; Volume 2, 376-393.
13. Hathcock, J.N.; Shao, A.; Vieth, R.; Heaney, R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85, 6-18.
14. Plum, L.A.; DeLuca, H.F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 2010, 9, 941-955.
15. Saliba, W.; Barnett, O.; Stein, N.; Kershenbaum, A.; Rennert, G. The longitudinal variability of serum 25(OH)D levels. Eur. J. Intern. Med. 2012, 23, e106-e111.
16. Heaney, R.P.; French, C.B.; Nguyen, S.; Baggerly, L.L.; Brunel, L.; Veugelers, P.J. A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin d continuum. Adv. Nutr. 2013, 4, 303-310.
17. Calgary Laboratry Services. Vitamin D, 25 Hydroxy. Available online: http://www.calgarylabservices.com/lab-services-guide/lab-tests/AlphabeticalListing/V/Vitamin-D-25-Hydroxy.htm (accessed on 9 December 2012).
18. Craig, C.L.; Marshall, A.L.; Sjostrom, M.; Bauman, A.E.; Booth, M.L.; Ainsworth, B.E.; Pratt, M.; Ekelund, U.; Yngve, A.; Sallis, J.F. et al. International physical activity questionnaire: 12-Country reliability and validity. Med. Sci. Sports Exerc. 2003, 35, 1381-1395.
19. Mello, M.M.; Stearns, S.C.; Norton, E.C.; Ricketts, T.C., III. Understanding biased selection in Medicare HMOs. Health Serv. Res. 2003, 38, 961-992.
20. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
21. Jackson, R.D.; LaCroix, A.Z.; Gass, M.; Wallace, R.B.; Robbins, J.; Lewis, C.E.; Bassford, T.; Beresford, S.A.A.; Black, H.R.; Blanchette, P. et al. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354, 669-683.
22. Wactawski-Wende, J.; Kotchen, J.M.; Anderson, G.L.; Assaf, A.R.; Brunner, R.L.; O'Sullivan, M.J.; Margolis, K.L.; Ockene, J.K.; Phillips, L.; Pottern, L. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 2006, 354, 684-696.
23. Stroud, M.L.; Stilgoe, S.; Stott, V.E.; Alhabian, O.; Salman, K. Vitamin D-A review. Aust. Fam. Phys. 2008, 37, 1002-1005.
24. Holick, M.F. Vitamin D deficiency: What a pain it is. Mayo Clin. Proc. 2003, 78, 1457-1459.
25. Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 2001, 22, 477-501.
26. Drincic, A.T.; Armas, L.A.; van Diest, E.E.; Heaney, R.P. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012, 20, 1444-1448.
27. Heaney, R.P.; Holick, M.F. Why the iom recommendations for vitamin D are deficient. J. Bone Miner. Res. 2011, 26, 455-457.
28. Pittas, A.G.; Chung, M.; Trikalinos, T.; Mitri, J.; Brendel, M.; Patel, K.; Lichtenstein, A.H.; Lau, J.; Balk, E.M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 2010, 152, 307-314.
29. Scragg, R. Vitamin D and Cardiovascular Disease: A Review of the Epidemiological and Clinical Evidence. In Vitamins in the Prevention of Human Diseases; Herrmann, W., Obeid, R., Eds.; Walter de Gruyter GmbH & Company KG: Berlin, Germany, 2011.
30. Heaney, R.P. Vitamin D-Baseline status and effective dose. N. Engl. J. Med. 2012, 367, 77-78.
31. Gallagher, J.C.; Sai, A.; Templin, T., II; Smith, L. Dose response to vitamin D supplementation in postmenopausal women: A randomized trial. Ann. Intern. Med. 2012, 156, 425-437.
32. Lips, P.; Wiersinga, A.; van Ginkel, F.C.; Jongen, M.J.; Netelenbos, J.C.; Hackeng, W.H.; Delmas, P.D.; van der Vijgh, W.J. The effect of vitamin D supplementation on vitamin d status and parathyroid function in elderly subjects. J. Clin. Endocrinol. Metab. 1988, 67, 644-650.
33. Ginde, A.A.; Sullivan, A.F.; Mansbach, J.M.; Camargo, C.A., Jr. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the united states. Am. J. Obstet. Gynecol. 2010, 202, 431-438.
34. Ginde, A.A.; Liu, M.C.; Camargo, C.A., Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med. 2009, 169, 626-632.
35. Langlois, K.; Greene-Finestone, L.; Little, J.; Hidiroglou, N.; Whiting, S. Vitamin D status of canadians as measured in the 2007 to 2009 Canadian Health Measures Survey. Health Reports 2010, 21, 47-55.